MedTrace Logo

Identification of Respiratory Profiles From Nasal Pressure Signals

NCT03753386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-09-16

No results posted yet for this study

Summary

Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory disease caused by smoking and associated with significant morbidity due to recurrent exacerbations or even hospitalizations. It is one of the leading causes of death in rich countries.

Early detection of exacerbations of the disease is thus an economic and public health issue in the world. Finding tools for automatic and early detection of an exacerbation is the subject of the study. A continuous analysis of the frequency and shape of the patients' breathing will be used.

As a first step in this study, investigators want to measure the frequency and shape of breathing in healthy subjects as they execute standard activities. These activities include resting, drinking, coughing, speaking, breathing through the mouth, physical exercise and recuperation.

Conditions

  • Healthy

Interventions

OTHER

Oxygen therapy simulation

The intervention consists of reproducing oxygen therapy situations in healthy individuals by replacing oxygen bottles with bottles of air. A TeleOx® device will be placed on the circuit between the source and the nasal cannula for respiratory signals recording. The intervention will last 30 minutes, containing the following activities in the given order: * rest (9 minutes); * drinking water (1 minute); * rest (1 minute); * coughing (1 minute); * rest (1 minute); * reading aloud (1 minute); * rest (1 minute); * breathing by the mouth (1 minute); * rest (1 minute); * exercising (running) (3 minutes) and * rest (10 minutes) Recordings will be retrieved after each test.

Sponsors & Collaborators

  • SRETT

    collaborator UNKNOWN

  • Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

    lead OTHER

Principal Investigators

  • Jesus Gonzalez-Bermejo · Groupe Hospitalier Pitié-Salpêtrière

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-16
Primary Completion
2019-05-16
Completion
2019-05-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03753386 on ClinicalTrials.gov